Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP & Controller | July 24, 2008 | July 25, 2008 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date July 24, 2008 · Filed July 25, 2008
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2018-07-23 | Direct | 7,500 |
Reported balance
After 2008-07-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2008-07-24 · Grant · Acquired 7,500 · Balance 7,500 F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2006 Filed Dec 5, 2006 19:02 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 178 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000108 · edgar.xml · derivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,960 Underlying: Common Stock · 178 shares Expires 2014-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:02 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 72 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000108 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,138 Underlying: Common Stock · 72 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/11/2003. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:02 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $44.28 | $11,070.00 |
DisclosureSEC source: 0000875320-06-000108 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,297 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:02 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 178 | $9.69 | $1,724.82 |
DisclosureSEC source: 0000875320-06-000108 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:02 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 72 | $9.07 | $653.04 |
DisclosureSEC source: 0000875320-06-000108 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:37 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $43.87 | $13,161.00 |
DisclosureSEC source: 0000875320-06-000106 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,297 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 27, 2006 Filed Nov 28, 2006 17:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000102 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,210 Underlying: Common Stock · 250 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/11/2003. Read SEC document |
| November 27, 2006 Filed Nov 28, 2006 17:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $43.72 | $10,930.00 |
DisclosureSEC source: 0000875320-06-000102 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 27, 2006 Filed Nov 28, 2006 17:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $9.07 | $2,267.50 |
DisclosureSEC source: 0000875320-06-000102 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2006 Filed Nov 21, 2006 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-06-000100 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,460 Underlying: Common Stock · 250 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 06/07/1999. Read SEC document |
| November 20, 2006 Filed Nov 21, 2006 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $44.83 | $11,207.50 |
DisclosureSEC source: 0000875320-06-000100 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 20, 2006 Filed Nov 21, 2006 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $11.18 | $2,795.00 |
DisclosureSEC source: 0000875320-06-000100 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 21:20 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 267 | $43.94 | $11,731.98 |
DisclosureSEC source: 0000875320-06-000096 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 13, 2006 Filed Nov 14, 2006 16:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-06-000094 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,710 Underlying: Common Stock · 250 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 06/07/1999. Read SEC document |
| November 13, 2006 Filed Nov 14, 2006 16:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $42.57 | $10,642.50 |
DisclosureSEC source: 0000875320-06-000094 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 13, 2006 Filed Nov 14, 2006 16:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $11.18 | $2,795.00 |
DisclosureSEC source: 0000875320-06-000094 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-06-000093 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,960 Underlying: Common Stock · 250 shares Expires 2009-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 06/07/1999. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $41.58 | $10,395.00 |
DisclosureSEC source: 0000875320-06-000093 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 09, 2006 Filed Nov 13, 2006 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $11.18 | $2,795.00 |
DisclosureSEC source: 0000875320-06-000093 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2006 Filed Nov 2, 2006 20:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $40.31 | $12,093.00 |
DisclosureSEC source: 0000875320-06-000090 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 30, 2006 Filed Oct 31, 2006 19:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 250 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-06-000088 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,210 Underlying: Common Stock · 250 shares Expires 2009-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 06/07/1999. Read SEC document |
| October 30, 2006 Filed Oct 31, 2006 19:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $39.80 | $11,940.00 |
DisclosureSEC source: 0000875320-06-000088 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,897 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 30, 2006 Filed Oct 31, 2006 19:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $40.19 | $10,047.50 |
DisclosureSEC source: 0000875320-06-000088 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,197 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 30, 2006 Filed Oct 31, 2006 19:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $11.18 | $2,795.00 |
DisclosureSEC source: 0000875320-06-000088 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2006 Filed Jul 24, 2006 17:43 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $35.35 | $0.00 |
DisclosureSEC source: 0000875320-06-000064 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,460 Underlying: Common Stock · 7,500 shares Expires 2016-07-19 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2006. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:43 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 15,422 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0000875320-06-000013 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,960 Underlying: Common Stock · 15,422 shares Expires 2016-02-01 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/02/2006. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:43 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 3,000 | $0.01 | $30.00 |
DisclosureSEC source: 0000875320-06-000013 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,864 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting on 02/02/2010, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| July 20, 2005 Filed Jul 22, 2005 19:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 2,391 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0000875320-05-000046 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,538 Underlying: Common Stock · 2,391 shares Expires 2015-07-19 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2005. Read SEC document |
| February 03, 2005 Filed Feb 7, 2005 21:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,955 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-05-000010 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,147 Underlying: Common Stock · 1,955 shares Expires 2015-02-02 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/03/2005. Read SEC document |
| February 03, 2005 Filed Feb 7, 2005 21:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 634 | $0.01 | $6.34 |
DisclosureSEC source: 0000875320-05-000010 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting on 02/03/2009, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| October 07, 2004 Filed Oct 12, 2004 18:45 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock · Derivative | 1,261 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-04-000109 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,192 Underlying: Common Stock · 1,261 shares Expires 2014-10-06 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| March 17, 2004 Filed Mar 19, 2004 20:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock · Derivative | 1,416 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-04-000021 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,931 Underlying: Common Stock · 1,416 shares Expires 2014-03-16 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 3/17/2004. Read SEC document |
| March 17, 2004 Filed Mar 19, 2004 20:12 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 279 | $0.01 | $2.79 |
DisclosureSEC source: 0000875320-04-000021 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 03/17/2004. Read SEC document |
| December 11, 2003 Filed Dec 15, 2003 21:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock · Derivative | 514 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-03-000060 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,515 Underlying: Common Stock · 514 shares Expires 2013-12-10 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003. Read SEC document |
| December 11, 2003 Filed Dec 15, 2003 21:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-03-000060 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.